Star Combo Pharma (ASX:S66) FY2018 wrap

Star Combo Pharma (ASX:S66) FY2018 wrap

Star Combo Pharma Limited 

 CEO, Su Zhang discusses the company’s FY2018 highlights, including growing its branded products, key distribution partners and its successful listing on the ASX.

Jessica Amir: Hello I’m Jessica Amir for the Finance News Network. Joining me now from Star Combo Pharma Limited  is CEO, Su Zhang. Hi Su and welcome back to the Network.

Su Zhang: Hi Jess, how are you?

Jessica Amir: Good thanks. So for those who aren’t familiar. Just give us a quick introduction and tell us where the business is at today?

Su Zhang: Star Combo Pharma Limited  currently is trading on the ASX, under the code S66. It’s a company dedicated to making vitamins, supplements and skincare products, based in Smithfield. Our current facility is 15,000 square metres, it’s a modern facility production site and we are a TGA-licensed business that both do contracting for other brands, as well as our own. Everything in our facility is made in Australia and owned in Australia.

Jessica Amir: When we last caught up, you spoke about brand growth. Just tell us how is that going?

Su Zhang: We have multiple brands in different categories. Now we compete on quality and price for these product lines. The benefit of our product is that 100 per cent of the products are made in our local Australian based production site. So we have full control over the traceability and the quality control of these product lines. We also have fully distinguished products with unique formulas, utilizing clinically trialled ingredients to be able to differentiate our products, from others in the marketplace. A number of our key marketing initiatives have already commenced. One of them is our massive billboards, you should be able to see them now at Sydney Town Hall Station.

Jessica Amir: What’s your strategy for exports and online sales?

Su Zhang: For our export part and online sales, it actually ties in together. Now for a major market that we are currently looking at, is the China market. In order to reach that export market, we are focusing on delivering our online sales via some major e-commerce platforms in China, such as . So the Living Healthy range is currently on there and also

Jessica Amir: Now to the IPO, it was one of the most successful IPOs of 2018 and you only listed in May. But for people who don’t know just tell us, what really fuelled that massive rally?

Su Zhang: We’re extremely happy with the outcome of the IPO. We attribute that mostly to a long business history of showing the market that we run a profitable business. The business has a long-standing history with the establishment in 2004. We’ve got a TGA licence with a full scope of manufacturing capabilities. That’s not very commonly seen in the market space. And the best thing is that we’ve got a selection of good retail product. And for our investors, we’ve got a really good mix of both retail and institutional investors.

Jessica Amir: Lastly, Su, what can investors expect for the second half of the year?

Su Zhang: We have a couple of news flows. The first one, which is already released to market, is that Dr Ziye Sui, the CEO of Lepu Hushengtang Internet Technology will be joining our Board as a valuable Non-Executive Director. The second one is that we will be setting up the employee share option, for our current employees. This is a phenomenal contribution to thank our current employees, and also to attract any new talent into our business. We want you.

And the third one to expect is our Financial Year 2018 Report that will come out in August. Shortly following that, we probably will have a series of big announcements, but I can’t say too much at this point in time.

Jessica Amir: Always a pleasure Su Zhang, thank you so much for your time.

Su Zhang: Thank you Jess.


Leave a Reply

Translate »